Evidence map›Paper›PMID 39568322›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Enantioselective Assembly of Fully Substituted α-Amino Allenoates Through a Mannich Addition and Stepwise [3,3]-σ Rearrangement Sequence.

Haoxuan Yuan, Yi Zhou, Xiongda Xie, Ming Bao, Kewei Chen, Kemiao Hong, Zhixiang Yu, Xinfang Xu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Haoxuan YuanSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
Yi ZhouBeijing National Laboratory for Molecular Sciences (BNLMS), Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry, Peking University, Beijing, 100871, China.
Xiongda XieSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
Ming BaoSchool of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Kewei ChenSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
Kemiao HongSchool of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Zhixiang YuBeijing National Laboratory for Molecular Sciences (BNLMS), Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry, Peking University, Beijing, 100871, China.
Xinfang XuSchool of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, China.ORCID https://orcid.org/0000-0002-8706-5151

Funding

National Natural Science Foundation of China 22371309
6 · The paper itself

Abstract

Chiral fully-substituted allenes are synthetically significant and pivotal building blocks that can engage in diverse transformations toward a variety of bioactive molecules. The enantioselective assembly of these skeletons using readily available reactants offers significant advantages but remains challenging. Herein, an asymmetric formal Michael-type addition of alkynyl imines with the key alkylgold intermediates derived in situ from N-propargylamides is accomplished under gold-complex and chiral quinine-derived squaramide (QN-SQA) synergetic catalysis. Control experiments and the density functional theory (DFT) calculations indicated that this cascade reaction involves a Mannich-type addition and stepwise [3,3]-σ rearrangement sequence, leading to the fully substituted α-amino allenoates, which are elusive and take multi-step to prepare with other methods, in high yields and excellent enantioselectivity.

Indexed as

alkyne functionalizationasymmetric catalysiscooperative catalysisgold catalysisα‐amino allenoate

Identifiers

PMID39568322
PMCPMC11727130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.